Hasil Pencarian - David Planchard

Perbaiki Hasil
  1. 1
    inhibitors in non-small cell lung cancer: the latest evidence and developments

    inhibitors in non-small cell lung cancer: the latest evidence and developments oleh Ivana Sullivan, David Planchard

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer

    Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer oleh Pamela Abdayem, David Planchard

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Osimertinib in the treatment of patients with epidermal growth factor receptor T790M mutation-positive metastatic non-small cell lung cancer: clinical trial evidence and experience

    Osimertinib in the treatment of patients with epidermal growth factor receptor T790M mutation-positive metastatic non-small cell lung cancer: clinical trial evidence and experience oleh Ivana Sullivan, David Planchard

    Diterbitkan 2016-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Durvalumab for stage III non-small-cell lung cancer patients: clinical evidence and real-world experience

    Durvalumab for stage III non-small-cell lung cancer patients: clinical evidence and real-world experience oleh Angela Botticella, Laura Mezquita, Cecile Le Pechoux, David Planchard

    Diterbitkan 2019-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape

    BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape oleh David Planchard, Rachel E. Sanborn, Marcelo V. Negrao, Aria Vaishnavi, Egbert F. Smit

    Diterbitkan 2024-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Author Correction: BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape

    Author Correction: BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape oleh David Planchard, Rachel E. Sanborn, Marcelo V. Negrao, Aria Vaishnavi, Egbert F. Smit

    Diterbitkan 2024-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Durable Response to the Combination of Atezolizumab With Platinum-Based Chemotherapy in an Untreated Non-Smoking Lung Adenocarcinoma Patient With BRAF V600E Mutation: A Case Report

    Durable Response to the Combination of Atezolizumab With Platinum-Based Chemotherapy in an Untreated Non-Smoking Lung Adenocarcinoma Patient With BRAF V600E Mutation: A Case Report oleh Xiaomin Niu, Yingjia Sun, David Planchard, Luting Chiu, Jian Bai, Xinghao Ai, Shun Lu

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report

    Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report oleh Myriam Mirza, Aseem Shrivastava, Cecile Matthews, Natasha Leighl, Calvin S. H. Ng, David Planchard, David Planchard, Sanjay Popat, Sanjay Popat, Sanjay Popat, Julia Rotow, Egbert F. Smit, Ross Soo, Masahiro Tsuboi, Fan Yang, Brendon Stiles, Christian Grohe, Yi-Long Wu

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer.

    Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer. oleh Antoine Schernberg, Laura Mezquita, Angela Boros, Angela Botticella, Caroline Caramella, Benjamin Besse, Alexandre Escande, David Planchard, Cécile Le Péchoux, Eric Deutsch

    Diterbitkan 2018-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    463 Vibostolimab plus pembrolizumab with/without docetaxel vs docetaxel in NSCLC after platinum chemotherapy and immunotherapy

    463 Vibostolimab plus pembrolizumab with/without docetaxel vs docetaxel in NSCLC after platinum chemotherapy and immunotherapy oleh Dae Ho Lee, Silvia Novello, Solange Peters, Balazs Halmos, David Planchard, Rodryg Ramlau, Christian Schumann, Niyati Bhagwati, Diana (Qiusheng) Chen, Debra Kush

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Staging of nutrition disorders in non‐small‐cell lung cancer patients: utility of skeletal muscle mass assessment

    Staging of nutrition disorders in non‐small‐cell lung cancer patients: utility of skeletal muscle mass assessment oleh Sami Antoun, Hugues Morel, Pierre‐Jean Souquet, Veerle Surmont, David Planchard, Franck Bonnetain, Pascal Foucher, Thomas Egenod, Ivan Krakowski, Hélène Gaudin, Didier Debieuvre

    Diterbitkan 2019-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer

    ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer oleh Enriqueta Felip, Solange Peters, Alfredo Addeo, Martin Reck, Antonio Passaro, Christophe Von Garnier, Fiona Blackhall, David Planchard, Rafal Dziadziuszko, Filippo de Marinis, Hasna Bouchaab

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Integrin-αV-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade

    Integrin-αV-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade oleh Ines Malenica, Julien Adam, Stéphanie Corgnac, Laura Mezquita, Edouard Auclin, Isabelle Damei, Laetitia Grynszpan, Gwendoline Gros, Vincent de Montpréville, David Planchard, Nathalie Théret, Benjamin Besse, Fathia Mami-Chouaib

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer

    Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer oleh Antonin Levy, Jonathan Khalifa, Etienne Martin, Angela Botticella, Clément Quevrin, Pernelle Lavaud, Mihaela Aldea, Benjamin Besse, David Planchard, Fabrice Barlesi, Eric Deutsch, Carole Massabeau, Jérôme Doyen, Cécile Le Péchoux

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors

    Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors oleh Marianne Oulhen, Patrycja Pawlikowska, Tala Tayoun, Marianna Garonzi, Genny Buson, Claudio Forcato, Nicolò Manaresi, Agathe Aberlenc, Laura Mezquita, Yann Lecluse, Pernelle Lavaud, Charles Naltet, David Planchard, Benjamin Besse, Françoise Farace

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Immune-related arthritis following pelvic radiation therapy in a patient with lung cancer receiving long-term immune checkpoint blocker treatment: Case report

    Immune-related arthritis following pelvic radiation therapy in a patient with lung cancer receiving long-term immune checkpoint blocker treatment: Case report oleh Mihaela Aldea, Rakiba Belkhir, Emeline Colomba, Pierre Blanchard, Francois-Xavier Danlos, Angela Botticella, Mario Terlizzi, Eric Deutsch, Eric Deutsch, Cecile Le Péchoux, David Planchard, Jean-Marie Michot, Benjamin Besse, Antonin Levy, Antonin Levy

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer

    Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer oleh Caroline Robert, Aurélien Marabelle, Fabrice Barlesi, Samy Ammari, David Planchard, Siham Farhane, Paul-Henry Cournède, Pierre Decazes, Younes Belkouchi, Léo Mottay, Littisha Lawrance, Antoine de Prévia, Hugues Talbot, Florian Guisier, Tony Ibrahim, Pierre Vera, Nathalie Lassau

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Unexpected Cardiotoxicity in Patients With HER2-Mutant NSCLC Treated With Trastuzumab Deruxtecan: A Case Report

    Unexpected Cardiotoxicity in Patients With HER2-Mutant NSCLC Treated With Trastuzumab Deruxtecan: A Case Report oleh Mariona Riudavets, MD, PhD, Arshid Azarine, MD, MSc, Sondes Smaali, MD, Young-Wouk Kim, MD, Vincent Thomas de Montpréville, MD, Alina Miruna Grecea, MD, Charles Naltet, MD, Annas Gazzah, MD, David Planchard, MD, PhD

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay.

    Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay. oleh Jordi Remon, Aurelie Swalduz, David Planchard, Sandra Ortiz-Cuaran, Laura Mezquita, Ludovic Lacroix, Cecile Jovelet, Etienne Rouleau, Camille Leonce, Frank De Kievit, Clive Morris, Greg Jones, Kelly Mercier, Karen Howarth, Emma Green, Maurice Pérol, Pierre Saintigny, Benjamin Besse

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Complete Remission After Immunotherapy-Induced Abdominal Tuberculosis in a Patient With Advanced NSCLC Treated With Pembrolizumab: A Case Report

    Complete Remission After Immunotherapy-Induced Abdominal Tuberculosis in a Patient With Advanced NSCLC Treated With Pembrolizumab: A Case Report oleh Mariona Riudavets, PhD, Benjamin Wyplosz, PhD, Maria Rosa Ghigna, MD, Angela Botticella, MD, Pamela Abdayem, MD, Pauline Pradere, MD, Ines Kasraoui, MD, Charles Roux, MD, Cécile Le Pechoux, MD, Camilo Garcia, MD, David Planchard, MD, PhD

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: